TABLE 2.
Haematological and biochemical parameters of the study groups.
| Variable | Study groups |
F test | p* | ||
|---|---|---|---|---|---|
| Control | PLWH on HAART | Treatment-naïve PLWH | |||
| Haemoglobin (g/dL) | 13.5 | 10.8 | 9.7 | 64.635 | < 0.0001 |
| WBC (×109) | 4.2 | 4.9 | 5.5 | 1.737 | 0.19 |
| Platelet count (×109) | 289 | 191 | 194 | 0.31 | 0.86 |
| Creatinine (mmol/L) | 62.3 | 81.72 | 96.86 | 2.062 | 0.15 |
| Alanine transaminase (mmol/L) | 24.4 | 26.2 | 28.07 | 0.335 | 0.56 |
| Prothrombin time (s) | 12.44 | 12.80 | 12.81 | 1.720 | 0.18 |
| aPTT (s) | 36.65 | 36.06 | 36.39 | 0.731 | 0.48 |
aPTT, activated partial thromboplastin time; HAART, highly active antiretroviral treatment; PLWH, people living with HIV; WBC, white blood cell count.
*
Analysis of variance test applied.